Skip to main content
. 2022 Sep 5;141(1):11–21. doi: 10.1182/blood.2022017277

Table 3.

Factors associated with neonatal thrombocytopenia <50 × 109/L in 171 newborns

Neonatal thrombocytopenia (platelet count <50 × 109/L)
Univariable analysis
Multivariable analysis
Total(n = 136) No(n = 117) Yes(n = 19) Unadjusted odds ratio [95% CI] P value Adjusted odds ratio [95% CI] P value
Maternal platelet count at delivery < 50 × 109/L (n=127/109/18) 8 (6.3) 6 (5.5) 2 (11.1) 2.15 [0.40-11.57] .37
Maternal platelet count < 50 × 109/L within 3 months before delivery 44 (32.4) 33 (28.2) 11 (57.9) 3.5 [1.29-9.47] .01 4.07 [1.41-11.73] .009
Disease status at pregnancy diagnosis .14
 CR 62 (45.6) 57 (48.7) 5 (26.3) 1 (ref)
 R 59 (43.4) 49 (41.9) 10 (52.6) 2.33 [0.74-7.27]
 NR 15 (11.0) 11 (9.4) 4 (21.1) 4.15 [0.96-17.93]
Disease status worsening between M0 and M9 65 (47.8) 52 (44.4) 13 (68.4) 2.71 [0.96-7.61] .06
Previous history of neonatal thrombocytopenia 20 (14.7) 13 (11.1) 7 (36.8) 4.67 [1.56-13.96] .006 5.55 [1.72-17.89] .004
Previous splenectomy 16 (11.8) 13 (11.1) 3 (15.8) 1.50 [0.38-5.85] .56
Treatment to prepare delivery
IVIg and/or CT
58 (42.7) 47 (40.2) 11 (57.9) 2.05 [0.77-5.47] .15

The results are given as number of events (%).

CI, confidence interval; CR, complete response; CT, corticosteroids; IVIg, intravenous immunoglobulin; NR, nonresponse; R, response; ref, reference category.

Wald test from univariable logistic regression.

Multivariable logistic regression model, adjusted for maternal platelet count and previous history of neonatal thrombocytopenia.